RU96114420A - METHOD FOR TREATING PATIENTS WITH NEUROLOGICAL MANIFESTATIONS OF SPINE OSTEOCHONDROSIS - Google Patents

METHOD FOR TREATING PATIENTS WITH NEUROLOGICAL MANIFESTATIONS OF SPINE OSTEOCHONDROSIS

Info

Publication number
RU96114420A
RU96114420A RU96114420/14A RU96114420A RU96114420A RU 96114420 A RU96114420 A RU 96114420A RU 96114420/14 A RU96114420/14 A RU 96114420/14A RU 96114420 A RU96114420 A RU 96114420A RU 96114420 A RU96114420 A RU 96114420A
Authority
RU
Russia
Prior art keywords
neurological manifestations
spine
treating patients
osteochondrosis
spine osteochondrosis
Prior art date
Application number
RU96114420/14A
Other languages
Russian (ru)
Other versions
RU2120289C1 (en
Inventor
Е.Ф. Левицкий
Л.П. Шустов
А.А. Зайцев
Б.И. Лаптев
А.И. Шабалин
Н.А. Фролов
Е.И. Смирнов
Original Assignee
Томский научно-исследовательский институт курортологии и физиотерапии
Filing date
Publication date
Application filed by Томский научно-исследовательский институт курортологии и физиотерапии filed Critical Томский научно-исследовательский институт курортологии и физиотерапии
Priority to RU96114420A priority Critical patent/RU2120289C1/en
Priority claimed from RU96114420A external-priority patent/RU2120289C1/en
Application granted granted Critical
Publication of RU2120289C1 publication Critical patent/RU2120289C1/en
Publication of RU96114420A publication Critical patent/RU96114420A/en

Links

Claims (1)

Способ лечения неврологических проявлений остеохондроза позвоночника, включающий электрофорез лекарственных средств, отличающийся тем, что больным проводят электрофорез 0,9-1,1% раствора пантогематогена в изотоническом растворе NaCl в количестве 10-20 мл на процедуру, на шейно-грудной или пояснично-крестцовый отделы позвоночника паравертебрально в зависимости от локализации неврологических проявлений заболевания, на курс 10-12 процедур.A method for the treatment of neurological manifestations of osteochondrosis of the spine, including electrophoresis of drugs, characterized in that patients undergo electrophoresis of 0.9-1.1% pantohematogen solution in isotonic NaCl in an amount of 10-20 ml per procedure, on the cervicothoracic or lumbosacral sections of the spine paravertebral depending on the localization of the neurological manifestations of the disease, for a course of 10-12 procedures.
RU96114420A 1996-07-12 1996-07-12 Method for treating the cases of neurologic manifestations of osteochondrosis RU2120289C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96114420A RU2120289C1 (en) 1996-07-12 1996-07-12 Method for treating the cases of neurologic manifestations of osteochondrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96114420A RU2120289C1 (en) 1996-07-12 1996-07-12 Method for treating the cases of neurologic manifestations of osteochondrosis

Publications (2)

Publication Number Publication Date
RU2120289C1 RU2120289C1 (en) 1998-10-20
RU96114420A true RU96114420A (en) 1998-10-27

Family

ID=20183397

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96114420A RU2120289C1 (en) 1996-07-12 1996-07-12 Method for treating the cases of neurologic manifestations of osteochondrosis

Country Status (1)

Country Link
RU (1) RU2120289C1 (en)

Similar Documents

Publication Publication Date Title
CA2275504A1 (en) Pharmacogenetic methods for use in the treatment of nervous system diseases
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
GR3026602T3 (en) Morphogen-induced liver regeneration.
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
NO973589D0 (en) Medication for the treatment of obsessive compulsive problems, sleep apnea, sexual dysfunction, emesis and travel sickness
ITBO930059A0 (en) PROCEDURE TO OBTAIN TISSUE REGENERATION IN PERIODENTAL DENTISTRY THERAPY.
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ID23528A (en) THERAPEUTIC TREATMENT FOR SKIN DISORDERS
ZA975028B (en) Finger-pressure functioning health-aid instrument for improving blood circulation in the human body.
RU96114420A (en) METHOD FOR TREATING PATIENTS WITH NEUROLOGICAL MANIFESTATIONS OF SPINE OSTEOCHONDROSIS
TW427986B (en) 4-amino 6-substituted mycophenolic acid and derivatives
HUP9903688A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
HK1010784A1 (en) 4-amino derivatives of 5-substituted mycophenolic acid
BR9708037A (en) Method for the treatment of substance abuse
EA200200559A1 (en) METHOD OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE CONDITIONS
DE69800906D1 (en) Use of olanzapine in the manufacture of a medicament for the treatment of cerebral focal ischemia
RU97110384A (en) METHOD FOR TREATING VIBRATIONAL DISEASE
RU93046305A (en) METHOD OF TREATING EYE DISEASES
EP1009232A4 (en) Methods for treating insulin resistance and identifying patients at risk for the disease